17 Recruiting Hodgkin Lymphoma Phase 2 Clinical Trials
Active phase 2 studies for hodgkin lymphoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Hodgkin Lymphoma studiesPhase 2 Studies for Hodgkin Lymphoma
Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
📍 Karmanos Cancer Institute — Detroit, Michigan
View Study & Checklist ➔Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
📍 Children's Hospital of Alabama ( Site 0023) — Birmingham, Alabama
View Study & Checklist ➔PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)
📍 Karmanos Cancer Institute — Detroit, Michigan
View Study & Checklist ➔Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL
📍 University of Chicago Medicine — Chicago, Illinois
View Study & Checklist ➔Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma
📍 Packard Children's Hospital, Stanford University — Palo Alto, California
View Study & Checklist ➔Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
View Study & Checklist ➔Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
📍 University of Illinois Cancer Center — Chicago, Illinois
View Study & Checklist ➔A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
📍 City of Hope Cancer Center (Data Collection Only) — Duarte, California
View Study & Checklist ➔Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
📍 Concord Repatriation General Hospital — Concord, New South Wales
View Study & Checklist ➔Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma
📍 Hospital Regional Alta Especialidad Bajio — León, Guanajuato
View Study & Checklist ➔A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
View Study & Checklist ➔BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Phase 2 Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
📍 UT MD Anderson — Houston, Texas
View Study & Checklist ➔